![Karen B. Chapman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Karen B. Chapman is the founder of Origen Therapeutics, Inc. She worked as the Vice President-Research at OncoCyte Corp.
from 2011 to 2017.
Chapman holds a graduate degree from Cornell University and a doctorate degree from The Johns Hopkins University School of Medicine, which she received in 1991.
Tidigare kända positioner av Karen B. Chapman
| Företag | Position | Slut |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2017-03-22 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Grundare | - |
Karen B. Chapmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
19
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Health Technology |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
